Effect of exercise training on liver function in adults who are overweight or exhibit fatty liver disease: a systematic review and meta-analysis by Smart, NA et al.
This is a final author’s draft of a paper submitted for publication in Hepatology 2016 DOI: 
http://dx.doi.org/10.1136/bjsports-2016-096197 
1 
 
The effect of exercise training on liver function in adults who are 
overweight or exhibit fatty liver disease:  
A systematic review and Meta-Analysis. 
Smart N.A. PhD1, King N. PhD2, McFarlane J.R. PhD1, Graham P.L. PhD3, Dieberg 
G. PhD1 
Running Head: Exercise for fatty liver disease 
1. School of Science and Technology, University of New England, Armidale, 
NSW 2350, Australia. 
2. School of Biomedical and Healthcare Sciences, Plymouth University, 
Plymouth. PL4 8AA. UK 
3. Department of Statistics, Macquarie University, Sydney, NSW 2109, 
Australia 
Address for Correspondence: 
Associate Professor Neil Smart 
School of Science and Technology 
University of New England 
Armidale, NSW 2351, Australia 
E-mail: nsmart2@une.edu.au 
Tel:  +61 2 6773 4076 
Fax:  +61 2 6772 8997 
 
Word Count: 
Abstract: 265 
Main Text: 4696 
This is a final author’s draft of a paper submitted for publication in Hepatology 2016 DOI: 
http://dx.doi.org/10.1136/bjsports-2016-096197 
2 
 
Keywords:  exercise training, liver function, fatty liver disease 
 
Author Contributions 
Dr Nicola King is a post-doctoral lecturer who conducted some of the 
data extraction, study quality assessment and manuscript writing. 
Dr Gudrun Dieberg assisted with data searching, extraction, data 
checking, study quality assessment and writing and editing of the 
manuscript. 
Prof. Jim McFarlane assisted with the literature search, assessment of 
study quality and verified the accuracy of the main text and 
supplementary files section as well as contributing to writing and editing 
the main text. 
Dr Petra Graham, verified accuracy of data extraction, conducted 
analyses especially regarding heterogeneity, provided comprehensive 
statistical advice for the response to reviewers as well as contributing to 
the editing of the rebuttal and final revised text and provision of some of 
the figures. 
A/Prof. Smart was the team leader, who also assisted with study 
inclusion/exclusion, data extraction/analysis and writing and editing of 
both the main text and supplementary files. 
This work was completed without funding and here are no competing 
interests or financial disclosures for any of the authors. Ethical approval 
was not required as this was a literature-based analysis and there are no 
limitations on data sharing. 
Acknowledgements 
None 
 
 
 
 
 
This is a final author’s draft of a paper submitted for publication in Hepatology 2016 DOI: 
http://dx.doi.org/10.1136/bjsports-2016-096197 
3 
 
 
 
Abstract 
Objective Exercise training has been shown to have beneficial effects on liver 
function in adults overweight or with fatty liver disease. To establish which 
exercise program characteristics were likely to elicit optimal improvements. 
Design: Systematic review and meta-analysis of randomized, controlled trials.  
Data sources: Pub Med, CINAHL and Cochrane controlled trials registry 
searched (1966-October 2, 2015). 
Eligibility criteria for selecting studies: exercise intervention, with or without 
dietary intervention, versus usual care in adults undertaking, exercise training, 
who were overweight, obese or exhibited fatty liver disease (NAFLD or NASH). 
Results: We included 21 randomized controlled trials, totalling 1530 participants. 
Exercise intervention studies with total exercise program workload >10,000Kcal 
produced significant improvements in intrahepatic fat, -3.46% [95% CI -5.20, -
1.73], p<0.0001, I2=73%; Effect Size (SMD) -1.77 [-3.11, -0.42], p=0.01, I2=77%. 
When data from only exercise studies were pooled; there was a reduction in 
fasting free fatty acids (FFA) -74.15 µmol.L-1 [95% CI -118.47, -29.84], p=0.001, 
I2=67% with a large effect size (SMD) -0.94 [-1.36, -0.52], p<0.0001, I2=0%. When 
data from only exercise studies were pooled; there was a significant reduction 
in insulin MD -1.88 UL [95% CI -3.43, -0.34], p=0.02, I2=31%. The liver enzymes 
Alanine aminotransferase (ALT), aspartate aminotransferase (AST) and Gamma-
glutamyl transpeptidase (GGT) were not significantly altered with exercise.  
Conclusions Exercise training reduces intrahepatic fat and free fatty acids 
while increasing cardiorespiratory fitness. An aggregate exercise program 
energy expenditure (>10,000 Kcal) may be required to promote reductions in 
intrahepatic fat.  
Systematic review registration: Not registered. 
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SUMMARY 
 Several new published randomized, controlled trials of exercise 
intervention suggest, for the first time, non-esterified fatty acids are 
reduced with exercise intervention 
 Changes in intra-hepatic may be possible, but only in exercise programs 
that elicit >10,000Kcal of energy expenditure 
 Varied study interventions render it difficult to separate the relative 
effects of diet and exercise on liver function 
 
HOW MIGHT FINDINGS INFLUENCE CLINICAL PRACTICE 
 Imaging, rather than liver enzyme concentrations, should be used to 
assess liver status 
 Preferably 3 months of adherent exercise training, after baseline 
assessment, should ensue before liver imaging is repeated.  
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Introduction 
Central obesity is linked to raised serum liver enzymes and future risk of 
developing insulin resistance[1].  Fatty liver disease (FLD) and non-alcoholic 
fatty liver disease (NAFLD) are also associated with increased serum levels of 
liver enzymes[2]. FLD may be diagnosed through liver function tests and 
imaging, such as magnetic resonance imaging or ultrasound of the liver, to 
detect excess intrahepatic fat. Exercise can greatly assist in reducing obesity 
and FLD, mainly by improving weight loss through dietary changes and exercise 
and reducing alcohol consumption[3].  
Obesity and FLD are risk factors for diabetes and cardiovascular disease. The 
prevalence of FLD varies greatly from a 10–35% prevalence rate in the US with 
approximately 2–5% of patients with non-alcoholic steatohepatitis (NASH)[4], 
the more severe form of NAFLD.  
A 2012 systematic review by Thoma et al[5] examined the effects of diet and 
exercise on liver function, but although data pooling was not performed, the 
authors concluded that dietary induced weight loss may offer greater liver 
health benefits than exercise. A 2012 systematic review, of randomized and 
non-randomized controlled studies in obese and FLD populations, by Keating 
and colleagues examined intrahepatic liver fat content and Alanine 
aminotransferase (ALT). The pooled analysis reported that the former, but not 
the latter, was reduced with exercise training of 4-26 weeks duration[6].  A 
number of new studies, including two studies with >100 participants[7, 8], have 
been published after Keating’s analysis. Moreover, Keating et al. pooled data 
from different modalities of exercise (aerobic and resistance) and did not adjust 
for the great variation in exercise program durations (1-12 months), frequency 
(2-7 sessions weekly) and intensity. There are now sufficient randomized 
controlled trials available to conduct analyses of several additional outcome 
measures and to adjust for variation in exercise program characteristics to 
identify those that are most beneficial in patients with obesity and fatty liver 
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disease. Furthermore liver enzymes may not be sensitive enough to be the only 
measure of liver function or liver fat[9], so new studies mean other markers can 
be examined. 
The primary aim of this work was to conduct a systematic review and meta-
analyses to establish the effect of exercise training on surrogate markers of liver 
function in adults who were overweight or exhibited fatty liver disease. The 
secondary aim was to establish if there is an exercise program volume more 
likely to elicit optimal improvements in related health outcome measures. 
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Materials and Methods 
Search strategy 
Potential studies were identified by conducting a systematic search using Pub 
Med, www.ncbi.nlm.nih.gov/pubmed (1966 to October 2, 2015), the Pub Med 
search strategy can be seen in supplementary files. CINAHL and the Cochrane 
controlled trials registry were also searched (1966-October 2, 2015). The search 
strategy included the key concepts of overweight, obese, fatty liver disease, 
non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, lifestyle therapy, 
physical training and exercise training. These were combined with a sensitive 
search strategy to identify randomized controlled trials (Supplementary Figure 
S1). Titles and abstracts were screened by NS and GD and full-text articles were 
downloaded for those meeting inclusion criteria. Reference lists of papers found 
were also scrutinized for new references. All identified papers were assessed 
independently by two reviewers (GD and NS), a third reviewer (JM) was 
consulted to resolve disputes. Searches of published papers were also 
conducted up until October 2, 2015.  
Inclusions 
Randomized controlled trials of progressive aerobic, resistance, or combined 
exercise training in adults (>18 years) who were overweight or obese or 
exhibited fatty liver disease (NAFLD or NASH) were included. The definition of 
obese/overweight was made by the individual studies, but this was verified by 
checking baseline data. Combined exercise training was defined as 
interventions that utilized both aerobic and resistance training simultaneously. 
We included studies comparing two types of exercise (e.g. aerobic versus 
resistance) or exercise versus usual care. Included studies employed three 
sessions or more of exercise, in order to differentiate from acute exercise 
effects.  Studies involving dietary control or intervention groups were included 
only if the diet was the same between exercise and control groups allowing the 
independent effects of exercise to be examined. There were no language 
restrictions.  
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Exclusions 
Animal studies, review papers and non-randomized controlled trials were 
excluded. Studies with unmatched intervention versus control group 
participants were excluded. We also excluded studies of healthy, normal body 
mass participants as liver function was likely to be normal. Authors were 
contacted to provide missing data or to clarify if data was duplicated in 
multiple publications. Incomplete data, or data from an already included 
study, were excluded. Studies using interventions other than exercise and/or 
(e.g. electroacupuncture, ultrasound) were excluded. 
Data Extraction 
Data on outcome measures were archived in a database, data were 
extracted by NS and verified by GD, JM was consulted if discrepancies 
occurred. The outcome measures were: change in intrahepatic fat 
(percentage change), Alanine Aminotransferase (ALT), Aspartate 
Aminotransferase (AST), Gamma-glutamyl Transpeptidase (GGT), free fatty 
acids (FFA), body mass and body mass index, insulin, total cholesterol and peak 
VO2 Table 1. Volume – where possible energy expenditure for weekly and total 
exercise programs. We calculated energy expended by establishing oxygen 
consumption at the training intensity and using 5Kcal per litre of Oxygen 
consumed, thus establishing Kcals expended per minute. We then multiplied 
Kcals/min by session duration (mins) and then multiplied this by total number of 
sessions to calculate aggregate energy expenditure for each exercise 
program, this is an approach we have utilized previously[10, 11] [12]. We also 
conducted analysis of effects on interhepatic fat only in exercise programs that 
expended an aggregate of >10,000Kcals. 
Data Synthesis 
The meta package in R version 3.2.1 was used to complete the meta-analysis 
and generate forest plots[13, 14]. Pooled data are presented as mean 
differences (MD) and as the effect size Hedges’ g i.e. standardised mean 
differences (SMD) with 95% confidence interval for intervals with a significant 
MD. We chose a random effects model as we anticipated considerable 
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heterogeneity. A minimum of three studies was required for meta-analysis to be 
undertaken. Multivariate meta-analysis (using the metafor package)[15] with a 
random intercept for study was used for studies that compared more than one 
intervention group with a control. 
Meta-analyses were completed for continuous data by using the change in the 
mean and standard deviation of outcome measures. It is an accepted 
practice to only use post intervention data for meta-analysis but this method 
assumes that random allocation of participants always creates intervention 
groups matched at baseline for age, disease severity etc. Change in post 
intervention mean was calculated by subtracting baseline from post 
intervention values.  Data required was either (i) 95% confidence interval data 
for pre-post intervention change for each group or when this was unavailable 
(ii) actual p values for pre-post intervention change for each group or if only 
the level of statistical significance was available (iii) we used default p values 
e.g. p<0.05 becomes p=0.049, p<0.01 becomes P=0.0099 and p = not significant 
becomes p=0.05.  
Effect sizes are interpreted in the usual way [16]with an effect size of 0.2 defined 
as small, 0.5 defined as moderate and 0.8 or higher defined as large. 
Analyses 
Where sufficient studies were included, meta-analysis was performed for the 
following groups (i) aerobic versus resistance training studies (ii) exercise only 
versus control studies and (iii) exercise plus diet versus diet control studies.  
 
Several sub-analyses were conducted as follows: 
In order to avoid considerable heterogeneity[17] we only presented forest plots 
when I2 heterogeneity was <75%. In the exercise only interventions we 
conducted meta-analyses for: 
Free fatty acids (FFA), Gamma-Glutamyl Transpeptidase (GGT), Body Mass 
Index (BMI), Insulin and Total Cholesterol.  
Sensitivity Analysis 
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Heterogeneity 
Heterogeneity was quantified using the I2 test[18], as it does not inherently 
depend upon the number of studies considered. The I2 statistic and 
corresponding 95% confidence interval (CI) were presented, to gauge the 
degree of heterogeneity present in sample [18, 19]. I2 values range from 0% 
(homogeneity) to 100% (greater heterogeneity); a CI that does not include 0% 
indicates that the hypothesis of homogeneity is rejected, and an inference of 
heterogeneity is merited[18].  
 
Meta-analysis and forest plots are presented only for those studies in which the 
heterogeneity (as measured by I2) was <75%. Heterogeneity beyond this level 
was deemed too heterogeneous[17] to be sensibly pooled and while interest 
was in trying to identify factors responsible for the heterogeneity, none of the 
subsets contained the recommended minimum number of studies (10) to allow 
this. 
Publication Bias 
Egger bias tests (when at least 10 studies were included) and funnel plots[20] 
were provided to assess the risk of publication bias (supplementary files).  
Risk of Bias Assessment  
Study quality was assessed by using the TESTEX scale[21] - the Tool for the 
assEssment of Study qualiTy and reporting in EXercise (TESTEX) - a study quality 
and reporting assessment tool, designed specifically for use in exercise training 
studies. The main point of difference in TESTEX is that there are 
accommodations for: Activity monitoring in control groups to measure 
crossover to exercise by sedentary control patients; Assessment of the existence 
and method of activity monitoring in both exercise intervention and sedentary 
controls; Assessment of whether the relative exercise intensity remained 
constant and therefore potentially avoided de-training as participants initially 
adapt to new exercise programs; Assessment of whether periodic evidence-
based adjustment of exercise intensity is reported exercise volume and exercise 
expenditure Information on all exercise characteristics (intensity, duration, 
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frequency and mode) is provided to calculate exercise volume and exercise 
energy expenditure. 
 
This tool is a 15-point scale (5 points for study quality and 10 points for reporting) 
and addresses previously unmentioned quality assessment criteria specific to 
exercise training studies. Two reviewers NS and GD conducted the risk of bias 
assessment, JM was consulted of discrepancies occurred. 
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Results 
Studies included in the review 
Our initial search identified 53 manuscripts, hand searching of reference lists of 
included studies and key articles such as related reviews and the latest editions 
of relevant journals yielded a further 3 manuscripts. Out of 56 studies, 6 were 
excluded at first inspection as duplicates, 17 were not controlled trials of 
exercise therapy, 2 were excluded as they had participants <18 years, 2 were 
excluded as they were not randomized trials, 6 used unmatched interventions 
or comparator groups and 2 were counselling interventions encouraging 
exercise participation, leaving 21 included studies for analysis (PRISMA 
Statement - Figure 1).  
Description of Included Studies 
Our 21 included randomized controlled trials (25 intervention groups), had an 
aggregate of 1530 participants, 884 exercise participants and 646 controls. 
Table 2 summarizes included studies[7, 8, 22-40]. Supplementary Table S1 in the 
supplementary files summarizes the excluded controlled trials[41-52].  
 
Thirteen studies used only an exercise intervention and eight studies used both 
exercise and dietary interventions. Five studies utilized resistance exercise and 
15 utilized aerobic exercise, 4 studies also used combined aerobic and 
resistance exercise. Study duration ranged from 4 to 52 weeks, training 
frequency ranged from 2-5 times weekly with 20-60 minutes session duration. 
Aerobic training intensity ranged from 45-85% of peak VO2. Control groups were 
classified as sedentary, although some used a stretching routine. 
 
Measurement of Study Outcomes 
Of note is that only one of the included studies[40] used the gold standard liver 
biopsy method to assess liver function. Instead of direct assessment of liver 
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function several studies used plasma concentrations of liver enzyme as 
surrogate markers of liver function. Moreover a number of different techniques 
were used to quantify liver enzymes. 
 
Study Quality Assessment  
Median TESTEX score was assessed as 10 out of 15 by two reviewers NS and GD, 
three studies each scored 7, 8, or 11. Four studies scored 9 and five studies 
scored 10, one study scored 12, two studies scored 13 (Figuree 2). Of the TESTEX 
items the following were done particularly poorly in general; Allocation 
concealment only 5/21 studies; Blinding of Assessors 5/21; Physical activity 
monitoring in the control groups to check with sedentary controls crossed over 
to exercise 10/21; Assessment of energy expended during exercise 10/21. 
 
Summary of Change in Outcome Measures   
Only two included studies compared aerobic versus resistance training, as such 
this training group is not considered further. 
 
Change in Intrahepatic Fat 
Data on interhepatic fat (IHF) were available from 9 studies (12 intervention 
groups) of exercise, with or without dietary intervention.  Six study groups 
showed significant IHF reductions, one study showed a significant increase and 
5 studies showed no change.  
Exercise only studies had high heterogeneity (I2: 84.4% 95% CI 70.1%, 91.4%) and 
there were too few studies (6) to allow for investigation of the cause of the 
heterogeneity beyond the following subgroup analysis.  
 
When data from the exercise only versus control programs that expended an 
aggregate of>10,000Kcal were pooled; there was a reduction in interhepatic 
fat -3.46% [95% CI -5.20, -1.73], p<0.0001, I2=73% (95% CI 9%, 92%), sFigure 3. The 
effect size was large (SMD) -1.77 [-3.11, -0.42], p=0.01, I2=77%.  
Diet plus exercise studies had no evidence of heterogeneity (I2:0 95% CI 0%, 
84.2%) and indicated no evidence of a change in interhepatic fat between 
diet and exercise versus diet alone studies MD 0.87% (95% CI -0.07, 1.81), p=0.07 
(from a multivariate model). Effect size (SMD) was small to moderate 0.29   95% 
CI: (-0.19, 0.78). P= 0.24 
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Change in Body Mass and Body Mass Index (BMI) 
Fourteen exercise studies with or without dietary intervention (17 intervention 
groups) reported change in body mass. Nine groups reported a significant fall 
in body mass, 1 group reported a significant rise and 7 groups were equivocal.  
The exercise only body mass studies (n=7) exhibited substantial heterogeneity (I2 
95.1% 95% CI 92.6%, 96.8%) even in the multivariate analysis. The small number 
of studies precluded investigation of the heterogeneity. The diet and exercise 
studies showed less heterogeneity (I2 71.3% 95% CI 40.8% to 86.1%) but no 
evidence of a change in body mass in the multivariate meta-analysis model 
MD -2.94 Kg (95% CI -5.93, 0.04), effect size (SMD) was moderate -0.34   95% CI: 
(-0.55,  -0.13) P= 0.001. 
 
Eleven exercise study groups, with (n=5) or without (n=6) dietary intervention, 
reported change in BMI, with only 4 groups reporting a significant improvement, 
while the other 7 groups showed no change.  
 
Meta-analysis of the 5 diet and exercise BMI studies indicated substantial 
heterogeneity; I2 83% (95% CI  62%, 93%). The small number of studies precluded 
investigation of the heterogeneity. Meta-analysis of the effect of exercise only 
intervention studies on BMI found a no evidence of a change, MD -0.05 Kg.m-2 
[95%CI -0.16, 0.06] p=0.38, I2=37% (95% CI 0%, 75%), see Figure 4. The effect size 
was small to moderate; (SMD) -0.26 [-0.56, 0.04], p=0.09, I2=0%, and also 
indicated no change in BMI.  
 
Fasting free fatty acids (FFA) 
When data from all 9 exercise studies with or without dietary intervention (11 
intervention groups) were examined, only 5 groups reporting a significant 
improvement, while the other 6 groups showed no change.  
 
When data from only exercise studies were pooled using a multivariate meta-
analysis model; there was a reduction in fasting FFA -74.15 µmol.L-1 [95% CI -
118.47, -29.84], p=0.001, I2=67% (95% CI 32%, 85%), Figure 5. The effect size (SMD) 
indicated a large change in FFA -0.94 [-1.36, -0.52], p<0.0001, I2=0%. The 3 
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pooled diet and exercise studies exhibited substantial heterogeneity; I2 88% 95% 
CI (65%, 96%) and were not considered further.  
Liver Enzymes 
Alanine aminotransferase (ALT) 
Examination of data from 16 exercise studies with or without dietary intervention 
(20 intervention groups) revealed that ALT was not significantly altered in 10 
groups and was significantly reduced (improved) in 5 groups and increased in 5 
groups.  
The 9 pooled exercise only studies exhibited substantial heterogeneity (I2 91% 
95% CI 87%, 94%) and were not considered further. The 7 pooled diet and 
exercise studies exhibited high levels of heterogeneity (I2 73%, 95% CI 45%, 87%) 
with no evidence of a difference in effect between diet and exercise and diet 
control groups MD 0.96 IU.L-1 (95% CI -2.84, 4.76). Effect size (SMD) negligible 
0.01   95% CI: (-0.40,   0.42). P = 0.95.   
Aspartate aminotransferase (AST) 
When data from 9 exercise studies with or without dietary intervention (12 
intervention groups) were examined, there was no change in AST in 6 groups, 
while 3 groups showed a significant reduction and 3 groups showed a 
significant increase.  
The 4 pooled exercise only studies exhibited substantial heterogeneity (I2 88% 
95% CI 77%, 94%) and were not considered further. The 5 pooled diet and 
exercise studies exhibited high levels of heterogeneity (I2 61%, 95% CI 5%, 84%) 
with no evidence of a difference in effect between diet and exercise and diet 
control groups MD -0.68 IU.L-1 (95% CI -2.54, 1.18). Effect size (SMD) was small -
0.20   95% CI: (-0.73,   0.34). P= 0.47.   
 
Gamma-Glutamyl Transpeptidase (GGT) 
Data from 6 exercise studies with or without dietary intervention (7 intervention 
groups) showed there was no significant change in GGT in 6 groups, only one 
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group showed a significant reduction. Only two diet and exercise studies were 
included thus pooling was not performed for that group.  
 
When data from the 4 exercise only studies were pooled using a multivariate 
meta-analysis model; there was no significant reduction in GGT MD -3.52 IU.L-1 
[95%CI -8.37, 1.34] p=0.16, I2=71% (95% CI 26%, 89%), see Figure 6. The effect size 
(SMD) was moderate but the interval suggested no significant effect -0.30 [-
0.69, 0.09], p=0.13, I2=74%. 
 
Peak VO2  
Data from 8 exercise studies with or without dietary intervention (11 intervention 
groups) were examined, there was a significant improvement in cardio-
respiratory fitness in 6 groups but not in 5 groups. 
The 5 pooled exercise only studies exhibited substantial heterogeneity (I2 86% 
95% CI 75%, 92%) and were not considered further. The 3 pooled diet and 
exercise studies exhibited high levels of heterogeneity (I2 68%, 95% CI 8%, 89%) 
with no evidence of a difference in effect between diet and exercise and diet 
control groups MD -0.05 ml O2.kg-1.min-1 (95% CI -0.22, 0.12). Effect size (SMD) 
was small 0.1430   95% CI: (-0.5377,  0.8236). P= 0.68.     
 
Insulin 
Data from 11 exercise studies (12 intervention groups) with or without dietary 
intervention was analysed, there was a significant insulin reduction in 5 groups 
but no change in 6 groups, 1 group showed an increase in insulin. 
When data from the 4 exercise only studies were pooled; there was a significant 
reduction in insulin MD -1.88 IU.L-1 [95% CI -3.43, -0.34], p=0.02, I2=31% (95% CI 0%, 
75%),  Figure 7. The effect size was moderate but was not significant SMD -0.47 [-
1.07, 0.13], p=0.13, I2=63%. Pooling the 7 diet and exercise studies resulted in 
substantial heterogeneity, I2 78% [95% CI 57%, 89%] hence these results are not 
considered further. 
Total Cholesterol 
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Data from 12 exercise studies (12 intervention groups) with or without dietary 
intervention were considered, there was a significant total cholesterol reduction 
in 6 groups but no change in 7 groups. 
 
When data from the 6 exercise only studies were pooled; there was a significant 
reduction in total cholesterol MD -7.04 mg.dL-1 [-11.96, -2.13], p=0.005, I2=44%; 
(95% CI 0%, 78%), Figure 8 (top). The effect size was moderate; SMD -0.49 [-0.95, 
-0.03], p=0.035, I2=50%. 
When data from the 6 diet and exercise studies were pooled using a 
multivariate meta-analysis model; there was a significant reduction in total 
cholesterol MD -2.47 mg.dL-1 [-4.55, -0.39], p=0.020, I2=44%; (95% CI 0%, 78%), 
Figure 8 (bottom). The effect size was moderate; SMD -0.49 [-0.85, -0.13], 
p=0.008, I2=52%. 
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Table 1. List of outcome measures and other data extracted from included 
studies. 
Data Type Units 
Inter-Hepatic Fat  Outcome 
Measure 
% of interhepatic fat 
Body Mass Outcome 
Measure  
Mass in Kg 
Body Mass Index Outcome 
Measure 
Kg.m-2 
Free Fatty Acids Outcome 
Measure 
µmol.L-1 
Gamma-Glutamyl 
Transpeptidase 
Outcome 
Measure 
Serum IU.L-1 
Alanine Aminotransferase  Outcome 
Measure 
Serum IU.L-1 
Aspartate 
aminotransferase 
Outcome 
Measure 
Serum IU.L-1 
Peak VO2 Outcome 
Measure 
ml O2.kg-1.min-1 
Insulin Outcome 
Measure 
Serum IU.L-1 
Total Cholesterol Outcome 
Measure 
Serum mg./dL-1 
Session Duration  Co-variate Minutes 
Program Duration (Weeks) Co-variate Weeks 
Session Frequency  Co-variate Sessions Per Week 
Exercise Mode  Co-variate Type of Activity 
Exercise Intensity  Co-variate % Maximum Heart Rate  
Year Year of 
publication 
Year 
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Table 2. Included Studies – Exercise Programming Details 
STUDY Study 
Duration, 
Frequency & 
Session Times 
Intervention Exercise Intensity Total Exercise 
Program 
Energy 
Expenditure 
(Kcal) 
No. of 
Subjects 
Exercise 
(control) 
Method of 
IHF 
Assessment 
Exercise vs control or exercise vs exercise 
Al-Jiffri 2013 12 wks 
3 times/wk 
30 mins 
A v Control A: 65-75% Max 
HR 
NR A:50 
C:50 
Liver Biopsy 
Bacchi  
2013 
16 wks 
3 times/wk 
60 mins 
A vs R A: 60-65% HRR 
R: 70-80% IRM 
NR A: 13 
R: 17 
MRI 
Balducci 
2014 
52 wks 
2 times/wk 
NR 
C vs Control 55-75% peak VO2 
60% 1RM 
NR C: 303(303) NR 
Bonekamp 
2008 
26 wks 
3 times/wk 
45 mins 
C vs Control A: moderate 
R: 50% 1RM 
13,650 28 (17) MRS 
Hallsworth 
2011 
8 wks 
3 times/wk 
45-60 mins 
R vs Control 50-70% 1RM NR 11 (8) MRI 
Johnson 2009 4 wks 
3 times/wk 
30-45 mins 
A vs Control 50-70% peak VO2 3,800 12 (7) MRI 
Keating 2015 8wks 
LO:HI: 3 
days/wk 
60 mins, 180-
240min/wk 
HI:LO & 
LO:LO: 3 
days/wk 
45 mins, 90-
135min/wk 
LO:HI, 
HI:LO &  
LO:LO vs 
Control 
LO:HI 50% peak 
VO2 
HI:LO 70% peak 
VO2 
LO:LO 50% peak 
VO2 
LO:HI: 11.474 
HI:LO: 8,443 
LO:LO:4,838 
LO:HI: 12 
HI:LO: 12 
LO:LO: 12 
Con: 12 
MRS 
Levinger 2009 10 wks 
3 times/wk 
2-6 sets, 12-15 
rep 
R vs Control 75-85% 1RM NR HiMF: 
15(15) 
LoMF: 
12(13) 
NA 
Shojaee-
Moradie 2007 
6 wks 
3 times/wk 
20 mins 
A vs Control 60-85% peak VO2 3,586 10 (7) MRS 
Slentz 
2011 
34 wks 
3 times/wk 
19.2 km/wk 
1. A vs R 
2. A vs C 
A: 75% peak VO2 
R: 70% 1RM 
Not available A: 48 
R: 52 
C: 44 
CT 
Sullivan 2012 16 wks A vs Control 45-55% peak VO2 21,325 12 (6) MRS 
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5 times/wk 
30-60 mins 
Thompson 
2010 
24 wks 
4 times/wk 
30-60 mins 
A vs Control 50-70% peak VO2 NR 20 (21) NA 
Zelber-Sagi 
2014 
12 wks 
3 times/wk 
40 mins 
R vs Control NR NR 33 (31) Ultrasound 
Exercise and diet vs diet 
Al-Jiffri 2013 12 wks 
3 times/wk 
30 mins 
A vs Control 65-75% MHR NR 50 (50) NR 
Bozetto 2012 8 wks 
2 times/wk 
45 mins 
Diet 1 & A vs 
Diet 1  
Diet 2 & A vs  
Diet 2 
70% peak VO2 3,320 Diet 1&A: 
10 (9) 
Diet 2&A: 9 
(8) 
MRS 
Goodpaster 
2010 
52 wks A or  26 
wks Con 
5 times/wk 
60 mins 
Diet & A vs 
Diet 
Diet & A: 12 m 
moderate 
Diet: 6 m 
moderate  
NR Diet & A: 
67 (63) 
CT 
Larson-Meyer  
2008 
26 wks 
5 times/wk 
individualized 
Diet & A vs 
Diet 
NR individualized Diet & A: 
11 (12) 
MRS 
Promrat 2010 10,000 
steps/day 
 
Diet & A vs 
Diet 
Moderate NA Diet & A: 
21 (10) 
NR 
Shah 2009 26 wks 
3 times/wk 
90 mins 
Diet & C vs 
Diet 
70-85% MHR or 
65-80% 1RM 
23,400 Diet & C: 9 
(9) 
MRS 
Straznicky 
2012 
12 wks 
3.5 times/wk 
40 mins 
Diet & A vs 
Diet 
65% MHR 15,294 Diet & A: 
19 (20) 
NA 
Tamura 2005 2 wks 
5-6 times/wk 
2-3x30 min 
Diet & A vs 
Diet 
50-60% peak VO2 NR Diet & A: 7 
(7) 
MRS 
Yoshimura 
2014 
12 wks 
3 times/wk 
60 mins plus 
120 mins/wk 
walking 
300 min/wk 
Diet & A vs 
Diet  
Moderate 3,067 Diet & A: 
15 (18) 
CT 
 
Legend: 
A – Aerobic exercise, BMI – Body Mass Index, C – Combined aerobic plus 
resistance exercise, Con – control, CT – Computed Tomography, HI:LO – high 
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intensity:low volume aerobic exercise, HiMF – high metabolic risk factors, HRR – 
Heart Rate Reserve, LO:HI – low intensity:high volume aerobic exercise, LO:LO – 
low intensity:low volume aerobic exercise, LoMF – low metabolic risk factors, 
MHR – Maximum Heart Rate, mins – minutes, MRI – Magnetic resonance 
imaging, MRS – Magentic resonance spectroscopy, NA – not applicable, NR – 
not reported, R – Resistance exercise, 1RM – 1 repetition maximum, vs – versus, 
wk - week. 
 
 
 
 
 
 
 
 
 
 
 
Risk of Bias Assessment 
The similarity in sample and effect sizes between randomized, controlled trials 
used in the analysis and those trials that were excluded from analysis suggests 
selection bias is minimal. The sample sizes are small however there is no 
apparent bias evident in the Egger plots (Supplementary Figures). 
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Discussion 
This work analysed the effects of exercise training, with or without dietary 
intervention, on intrahepatic fat, body mass, body mass index, free fatty acids, 
insulin liver enzymes, lipids and cardiorespiratory fitness (peak VO2). Our primary 
findings show that exercise training, in isolation from dietary intervention, has 
beneficial effects on some of these aforementioned outcome measures. We 
were able to establish that intrahepatic fat loss may be optimized by utilization 
of greater total exercise training energy expenditure. It appears that the 
addition of recently published work has added diversity to the current evidence 
base and increasingly varied study designs have necessitated a more cautious 
approach to data pooling and subsequent meta-analysis. 
Our work failed to show changes in any of the three primary liver enzymes with 
exercise training. The number of participants included in these three analyses 
varied between 797 and 1109, so it unlikely that these analyses were 
underpowered. There were however several confounding variables in the 
included studies that may have prevented the isolated effects of exercise to be 
examined. There were eight studies that, in addition, to exercise training also 
provided various dietary interventions. Moreover, the exercise training programs 
varied greatly between studies with respect to exercise intensity, duration, 
frequency and modality (eg aerobic versus resistance training). Whatever the 
reason for the absence of significant changes, our work confirms the previous 
findings that liver enzymes have limited sensitivity in detecting early liver 
disease[9]. It appears that liver enzymes are, at best, a blunt tool for assessing 
change in liver function after exercise training.  
Our analysis suggested that intrahepatic fat is reduced with exercise training, in 
as little as 4 weeks[27], but aerobic exercise programs of total energy 
expenditure >10,000Kcal are likely to elicit greater improvements than programs 
with lower exercise energy expenditure. Our findings in this respect advance 
those of Keating et al.[6] who conducted pooled analyses of all exercise 
modalities.  
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In mild fatty liver disease, the first choice therapy is lifestyle modification, 
although medications that decrease insulin resistance, hyperlipidaemia, and 
those that induce weight loss have been shown to improve liver function[53]. 
Our analysis reinforces the fact that even short term, exercise training is 
effective in reducing intrahepatic fat. These findings suggest that exercise may 
benefit liver health through a calorie expenditure mechanism, sufficient levels 
of which are acquired more rapidly with vigorous or high intensity exercise 
training. Data from heart failure studies suggests that high intensity exercise may 
promote superior health benefits[11]. 
It has been recognized that free fatty acids are the vehicle by which 
triacylglycerol is stored in adipose tissue and is transported to its site of 
utilization[54].  Free fatty acid turnover is rapid with a half-life of 2-4 minutes[54]. 
In our analysis, 3 studies using >10,000Kcal total exercise program energy 
expenditure appear to elicit greater reductions in intrahepatic fat. High volume 
exercise energy expenditure provides a variety of benefits related to metabolic 
disorders; we propose that one clinical benefit directly related to liver function is 
that high volume aerobic exercise elicits triacyglycerol consummation. Of 
course other exercise-induced benefits will accrue and primarily affect other 
organs, besides the liver, such as improved flow mediated vascular 
dilatation[55], cardiac function[56], peak VO2[55, 56] and weight loss which 
was minimal in our analysis. 
Our analyses suggest that it is calorie burning that elicits reductions in liver fat, 
reduced fat storage, possibly reduced liver enzymes and the sum of all of this is 
improved glycaemic control. Of perhaps most interest is that the above 
changes are achieved almost totally independent of body mass changes. To 
illustrate this we chose the study of Shoajee-Moradie[32], because this work was 
the only included study to utilize high intensity exercise and measure peak VO2, 
allowing calorie expenditure to be calculated. The exercise participants in 
Shoajee-Moradie’s study[32] expended 9.8 Kcal per minute, or 590 Kcal each 
week, the study only ran for 6 weeks. Exercise participants therefore only 
expended 3500 Kcal during the whole study, equivalent to 0.5 kg of fat. Not 
surprisingly, Shoajee-Moradie reported no change in body mass in either 
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exercise or control groups[32]. Nevertheless Johnson’s study[27] reported a 
similar aggregate exercise program energy expenditure (3800Kcal) but as it 
was delivered in a shorter 4-week period, changes in interhepatic fat were 
noted. 
Limitations 
A major limitation of this work was that considerable heterogeneity meant that 
data pooling was unjustified in a number of meta-analyses. We systematically 
attempted to identify reasons for heterogeneity by grouping studies according 
to similarities in interventions, exercise programs, patient populations, but we 
failed to identify definitive conclusions. We were able to reduce heterogeneity 
somewhat by limiting data pooling to studies that did not use concurrent 
dietary interventions. Some patients were overweight/obese while others had 
definitive liver disease, some of the former may well have also exhibited clinical 
NAFLD. The likelihood is that the potential for non-clinical NAFLD participants to 
‘regress to the mean’ was probably less than in those with diagnosed NAFLD.  
As discussed previously liver enzymes have limited predictive value for liver 
function and it is notable that only one of the included studies used the gold 
standard liver biopsy method to assess liver function.  There were studies that, in 
addition, to exercise training also provided various dietary interventions. The 
exercise training programs varied greatly between studies with respect to 
exercise intensity, duration, frequency and modality (eg aerobic versus 
resistance training). The normal distribution of the Egger plots evidenced 
minimal risk of publication bias.  
In the case of the liver enzymes, some heterogeneity may be explained by the 
naturally occurring inter-subject variation that exists with these enzymes. 
Measures of lean, and fat, body mass would have shed more light onto the role 
that body composition plays in improving liver function through exercise. We 
would like to have conducted sub-group analyses of those with normal and 
impaired liver function but group-level (as opposed to individual patient data) 
precluded this. We considered program duration, modality and frequency sub-
analyses but the variation in included study data precluded this. 
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Meta-regression between change in liver function and body mass was 
considered, but change in body mass was not reported in all studies. 
 
The current number of published studies does not allow meta-analyses to 
compare; aerobic versus resistance exercise; high intensity versus low or 
moderate intensity exercise; and effects of weekly exercise duration. All of 
which may influence change in current guidelines. 
The risk of bias assessment identified that allocation concealment to 
investigators was conducted in less than one quarter if studies and investigator 
bias is quite likely. Moreover assessor blinding was uncommon (only 5 of 21 
studies), so this would not mitigate allocation concealment. The lack of physical 
activity monitoring in 50% of the studies implies that there was likelihood that 
sedentary controls crossed over to exercise in some studies. The lack of 
assessment of energy expended during exercise in 10 studies meant that our 
meta-analyses of aggregate energy expenditure may not be fully 
representative. 
Future studies should aim to at least blind the outcome assessors to the 
participants’ intervention to minimise outcome assessment bias. Future work 
may also wish to focus on exercise induced calorie expenditure and the 
presence or absence of associated weight loss, in order to clarify the 
mechanism of benefit. Use of gold standard biopsy, rather than reliance on liver 
enzymes, assessment of liver function is recommended. 
 
Conclusions 
Exercise training reduces intrahepatic fat and free fatty acids while increasing 
cardiorespiratory fitness. An aggregate exercise program energy expenditure 
(>10,000 Kcal) may be required to promote reductions in intrahepatic fat.  
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